JCL roundtable: Apolipoproteins as causative elements in vascular disease

Area of Science:

• Cardiovascular Medicine
• Clinical Lipidology
• Genetics

Background:

• Traditional clinical lipidology focuses on cholesterol content for risk assessment and therapy targets.
• Current lipid measures, such as low-density lipoprotein cholesterol (LDL-C), can be variable and may not capture all relevant patient risk information.
• Abnormalities in lipoprotein particle number or composition can exist even with normal LDL-C levels.

Purpose of the Study:

• To highlight the limitations of cholesterol content in lipoproteins for defining vascular risk.
• To emphasize the importance of alternative lipid markers, including lipoprotein particle number and apolipoprotein C3 (apoC3) content.
• To explore how genetic studies inform our understanding of vascular risk factors.

Main Methods:

• Review of clinical lipidology practices and limitations of current lipid measures.
• Analysis of lipoprotein particle number, specifically apolipoprotein B (apoB)-containing particles.
• Investigation of apolipoprotein C3 (apoC3) content within apoB-lipoproteins.
• Incorporation of findings from genome-wide association studies and genetic polymorphism research.

Main Results:

• Lipoprotein cholesterol content is variable and may not accurately reflect individual patient risk.
• Elevated numbers of apolipoprotein B (apoB)-containing particles can indicate risk, even with guideline-adherent LDL-C levels.
• Apolipoprotein C3 (apoC3) content in apoB-lipoproteins predicts vascular risk independently of triglycerides or cholesterol levels.
• Genetic studies reveal significant relationships between specific genetic factors and vascular risk.

Conclusions:

• Clinical lipidology should consider lipoprotein particle number and apoC3 content for comprehensive vascular risk assessment.
• These advanced lipid markers offer valuable information beyond traditional cholesterol measurements for guiding patient therapy.
• Genetic insights are crucial for understanding the complex interplay of factors contributing to vascular risk.